SUPN logo

Supernus Pharmaceuticals, Inc. (SUPN) Shareholders Equity

Annual Shareholders Equity:

$1.04B+$114.22M(+12.39%)
December 31, 2024

Summary

  • As of today, SUPN annual stockholders equity is $1.04 billion, with the most recent change of +$114.22 million (+12.39%) on December 31, 2024.
  • During the last 3 years, SUPN annual shareholders equity has risen by +$219.88 million (+26.95%).
  • SUPN annual shareholders equity is now at all-time high.

Performance

SUPN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Quarterly Shareholders Equity:

$1.06B+$33.20M(+3.22%)
June 30, 2025

Summary

  • As of today, SUPN quarterly stockholders equity is $1.06 billion, with the most recent change of +$33.20 million (+3.22%) on June 30, 2025.
  • Over the past year, SUPN quarterly shareholders equity has increased by +$106.45 million (+11.12%).
  • SUPN quarterly shareholders equity is now at all-time high.

Performance

SUPN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SUPN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+12.4%+11.1%
3Y3 Years+26.9%+26.4%
5Y5 Years+74.0%+59.8%

SUPN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+26.9%at high+24.8%
5Y5-Yearat high+74.0%at high+50.1%
All-TimeAll-Timeat high+2436.9%at high+1567.0%

SUPN Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$1.06B(+3.2%)
Mar 2025
-
$1.03B(-0.5%)
Dec 2024
$1.04B(+12.4%)
$1.04B(+2.8%)
Sep 2024
-
$1.01B(+5.2%)
Jun 2024
-
$957.45M(+3.0%)
Mar 2024
-
$929.17M(+0.8%)
Dec 2023
$921.52M(+4.0%)
$921.52M(+1.0%)
Sep 2023
-
$912.19M(-0.8%)
Jun 2023
-
$919.91M(+0.9%)
Mar 2023
-
$912.15M(+2.9%)
Dec 2022
$886.20M(+8.6%)
$886.20M(+3.9%)
Sep 2022
-
$852.80M(+1.4%)
Jun 2022
-
$841.43M(+1.6%)
Mar 2022
-
$828.45M(+1.5%)
Dec 2021
$815.85M(+9.5%)
$815.85M(+0.7%)
Sep 2021
-
$810.47M(+3.2%)
Jun 2021
-
$785.58M(+4.1%)
Mar 2021
-
$754.44M(+1.3%)
Dec 2020
$744.86M(+25.1%)
$744.86M(+5.1%)
Sep 2020
-
$708.88M(+6.4%)
Jun 2020
-
$665.97M(+8.6%)
Mar 2020
-
$613.38M(+3.0%)
Dec 2019
$595.43M(+31.4%)
$595.43M(+6.8%)
Sep 2019
-
$557.26M(+6.6%)
Jun 2019
-
$522.90M(+8.9%)
Mar 2019
-
$480.02M(+6.0%)
Dec 2018
$453.02M(+69.4%)
$453.02M(+7.4%)
Sep 2018
-
$421.94M(+8.1%)
Jun 2018
-
$390.49M(+11.0%)
Mar 2018
-
$351.87M(+31.5%)
DateAnnualQuarterly
Dec 2017
$267.48M(+39.5%)
$267.48M(+6.3%)
Sep 2017
-
$251.66M(+9.7%)
Jun 2017
-
$229.40M(+11.3%)
Mar 2017
-
$206.06M(+7.5%)
Dec 2016
$191.75M(+117.9%)
$191.75M(+10.6%)
Sep 2016
-
$173.37M(+57.3%)
Jun 2016
-
$110.22M(+13.5%)
Mar 2016
-
$97.11M(+10.3%)
Dec 2015
$88.01M(+23.3%)
$88.01M(-19.6%)
Sep 2015
-
$109.44M(+52.4%)
Jun 2015
-
$71.82M(+12.7%)
Mar 2015
-
$63.75M(-10.7%)
Dec 2014
$71.35M(+113.2%)
$71.35M(+7.9%)
Sep 2014
-
$66.12M(+98.1%)
Jun 2014
-
$33.37M(+15.0%)
Mar 2014
-
$29.01M(-13.3%)
Dec 2013
$33.46M(-41.9%)
$33.46M(+168.7%)
Sep 2013
-
$12.45M(-65.3%)
Jun 2013
-
$35.89M(-13.0%)
Mar 2013
-
$41.27M(-28.3%)
Dec 2012
$57.57M(+4.9%)
$57.57M(+133.7%)
Sep 2012
-
$24.63M(-35.1%)
Jun 2012
-
$37.98M(>+9900.0%)
Mar 2012
-
$274.00K(-97.1%)
Dec 2011
$54.91M(+223.9%)
$9.44M(+113.0%)
Sep 2011
-
-$72.52M(-63.6%)
Dec 2010
-$44.32M(-620.0%)
-$44.32M(-23.4%)
Sep 2010
-
-$35.92M(-483.4%)
Dec 2009
-$6.16M(+8.8%)
-$6.16M
Dec 2008
-$6.75M
-

FAQ

  • What is Supernus Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is Supernus Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Supernus Pharmaceuticals, Inc.?
  • What is Supernus Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is Supernus Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of SUPN is $1.04B

What is the all-time high annual shareholders equity for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high annual stockholders equity is $1.04B

What is Supernus Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, SUPN annual stockholders equity has changed by +$114.22M (+12.39%)

What is Supernus Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of SUPN is $1.06B

What is the all-time high quarterly shareholders equity for Supernus Pharmaceuticals, Inc.?

Supernus Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $1.06B

What is Supernus Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, SUPN quarterly stockholders equity has changed by +$106.45M (+11.12%)
On this page